---
layout: post
title: "E6(R3) Good Clinical Practice: Annex 2; International Council for Harmonisation; Draft Guidance for Industry; Reopening of the Comment Period"
date: 2026-02-04 21:50:34 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-04026
original_published: 2025-03-13 00:00:00 +0000
significance: 8.00
---

# E6(R3) Good Clinical Practice: Annex 2; International Council for Harmonisation; Draft Guidance for Industry; Reopening of the Comment Period

**Published:** February 04, 2026 21:50 UTC
**Source:** Federal Register
**Original Published:** March 13, 2025 00:00 UTC
**Document Number:** 2025-04026

## Summary

The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the draft guidance for industry entitled "E6(R3) Good Clinical Practice: Annex 2," announced in the Federal Register of December 30, 2024. The Agency is taking this action to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/03/13/2025-04026/e6r3-good-clinical-practice-annex-2-international-council-for-harmonisation-draft-guidance-for)
- API: https://www.federalregister.gov/api/v1/documents/2025-04026

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
